Search - tctmd.com

Displaying 941 - 960 of 1091

Sort: Relevancy | Date

Presentation Fellows 2013

Left Main Disease: PCI vs CABG

Presenter: Gregg Stone

April 15, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Daily News

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Jason Kahn

March 25, 2013

News Conference News ACC 2013

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Jason Kahn

March 09, 2013

Presentation PCI Outcomes 2013

Clinical Decision Making for Unprotected Left Main Disease

Presenter: Nicholas J. Lembo

March 07, 2013

Presentation CTO 2013

Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging

Presenter: Antonio Colombo

February 22, 2013

News Daily News

CTA Charts Prognosis Even in Stable Patients Without Typical Risk Factors

Caitlin E. Cox

February 20, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry

Presenter: Renato Valenti, Angela Migliorini, Guido Parodi, Ruben Vergara, Nazario Carrabba, Emilio Vincenzo Dovellini, David Antoniucci

January 31, 2013

News Daily News

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Jason Kahn

January 24, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

SCAI Updates Recommendations for Ad Hoc PCI

Yael L. Maxwell

December 02, 2012

News Daily News

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

Kim Dalton

November 19, 2012

News Conference News AHA 2012

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

Jason Kahn

November 05, 2012

News Conference News AHA 2012

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

Jason Kahn

November 04, 2012

Presentation TCT 2012

Diabetes Mellitus, Multivessel, and Left Main Disease: Not So Fast, PCI for Many!

Presenter: Kevin Beatt

October 26, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

Presentation TCT 2012

Diabetes Mellitus, Multivessel, and Left Main Disease: CABG for All!

Presenter: Joseph Sabik

October 26, 2012

News Conference News TCT 2012

Novel Devices for Advanced HF on Horizon

October 26, 2012

Advertisement

Left Main Disease: PCI vs CABG

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Clinical Decision Making for Unprotected Left Main Disease

Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging

CTA Charts Prognosis Even in Stable Patients Without Typical Risk Factors

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

SCAI Updates Recommendations for Ad Hoc PCI

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

Diabetes Mellitus, Multivessel, and Left Main Disease: Not So Fast, PCI for Many!

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

Diabetes Mellitus, Multivessel, and Left Main Disease: CABG for All!

Novel Devices for Advanced HF on Horizon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content